You are here

Article Text

Article menu
Download PDFPDF
Prevention
Systematic review
Lung cancer screening with low-dose CT (LDCT) is ready for prime time in the USA
  1. David O Wilson
  1. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
  1. Correspondence to: Dr David O Wilson, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, 580 S. Aiken Avenue, #400, Pittsburgh, PA 15217, USA; wilsondo{at}upmc.edu

https://doi.org/10.1136/eb-2013-101611

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive Services Task Force recommendation. Ann Intern Med 2013;159:411–20.OpenUrlCrossRefPubMedWeb of Science

    Context

    The US Preventative Services Task Force (USPSTF) has published their long-awaited, updated systematic review of low-dose CT (LDCT) screening for lung cancer. Last reviewed in 2004, lung cancer screening has been under intense study worldwide for the past decade. The issue of lung cancer screening is important because lung cancer is the leading cause of cancer mortality in the USA and any method that improves lung cancer early detection and diagnosis has the potential to significantly impact …

    View Full Text

    Footnotes

    • Competing interests None.